Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,852 | -28,261 | -16,221 | -12,706 | -7,365 |
| Accounts payable and accrued liabilities | -660 | 3,011 | 1,631 | 1,874 | 675 |
| Other Working Capital | -1,140 | 8,929 | 2,098 | 2,625 | 1,148 |
| Other Operating Activity | 700 | -2,639 | -1,778 | -2,062 | -724 |
| Operating Cash Flow | $-7,951 | $-18,961 | $-14,270 | $-10,268 | $-6,267 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 668 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 20 | 7,793 | 7,774 | N/A | N/A |
| Financing Cash Flow | $687 | $7,793 | $7,774 | $0 | $0 |
| Beginning Cash Position | 18,520 | 29,688 | 29,688 | 29,688 | 29,688 |
| End Cash Position | 11,256 | 18,520 | 23,192 | 19,420 | 23,421 |
| Net Cash Flow | $-7,264 | $-11,168 | $-6,496 | $-10,268 | $-6,267 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,951 | -18,961 | -14,270 | -10,268 | -6,267 |
| Free Cash Flow | -7,951 | -18,961 | -14,270 | -10,268 | -6,267 |